17-4539758-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_014520.4(MYBBP1A):c.3644G>A(p.Arg1215Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014520.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBBP1A | NM_014520.4 | c.3644G>A | p.Arg1215Lys | missense_variant | 26/26 | ENST00000254718.9 | NP_055335.2 | |
MYBBP1A | NM_001105538.2 | c.3644G>A | p.Arg1215Lys | missense_variant | 26/27 | NP_001099008.1 | ||
MYBBP1A | XM_011523616.3 | c.2888G>A | p.Arg963Lys | missense_variant | 21/21 | XP_011521918.1 | ||
MYBBP1A | XM_024450536.2 | c.*144G>A | 3_prime_UTR_variant | 25/25 | XP_024306304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBBP1A | ENST00000254718.9 | c.3644G>A | p.Arg1215Lys | missense_variant | 26/26 | 1 | NM_014520.4 | ENSP00000254718.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152112Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250932Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135666
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460990Hom.: 0 Cov.: 36 AF XY: 0.0000124 AC XY: 9AN XY: 726858
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152112Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74298
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at